Hims & Hers Health, Inc. Form 8-K Summary
Business Context and Reporting Period
Hims & Hers Health, Inc. filed a Form 8-K dated November 7, 2022, under Item 2.02 to announce results of operations for the quarter ended September 30, 2022. The filing concerns the company’s Class A common stock, traded on the New York Stock Exchange under the symbol HIMS.
Financial Results and Key Metrics
The filing states that a press release announcing quarterly results was issued and furnished as Exhibit 99.1. The provided filing text does not include the press release’s financial data; therefore, revenue, profit or loss, cash flow, margins, debt, liquidity, subscriber metrics, and other key figures are not clearly provided.
Material Changes Versus the Prior Comparable Period
The provided text does not disclose quantitative or qualitative changes versus the prior-year comparable period.
Guidance, Outlook, Risks, and Unusual Items
The provided text does not include management guidance, outlook commentary, risk updates, contingencies, or unusual items. It only identifies the accompanying press release as the source of the quarterly results announcement.
Important Facts to Verify
- Obtain and review Exhibit 99.1 for the complete quarterly financial results.
- Verify revenue growth, profitability, adjusted metrics, cash flow, cash balance, debt, and liquidity.
- Review any updated full-year guidance and management commentary.
- Check subscriber, membership, revenue-per-user, and other operating metrics disclosed in the press release.
- Note that the information was furnished under Item 2.02 and is not deemed filed for purposes of Section 18 of the Exchange Act, except where expressly incorporated by reference.